SG11202111833YA - Composition for promoting glp-1 secretion - Google Patents

Composition for promoting glp-1 secretion

Info

Publication number
SG11202111833YA
SG11202111833YA SG11202111833YA SG11202111833YA SG11202111833YA SG 11202111833Y A SG11202111833Y A SG 11202111833YA SG 11202111833Y A SG11202111833Y A SG 11202111833YA SG 11202111833Y A SG11202111833Y A SG 11202111833YA SG 11202111833Y A SG11202111833Y A SG 11202111833YA
Authority
SG
Singapore
Prior art keywords
glp
secretion
sample
reba
composition
Prior art date
Application number
SG11202111833YA
Other languages
English (en)
Inventor
Soichiro Urai
Koji Nagao
Yoshiaki Yokoo
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG11202111833YA publication Critical patent/SG11202111833YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/36—Terpene glycosides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/60—Sweeteners
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202111833YA 2019-04-26 2020-04-22 Composition for promoting glp-1 secretion SG11202111833YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019086867 2019-04-26
PCT/JP2020/017399 WO2020218379A1 (ja) 2019-04-26 2020-04-22 Ｇｌｐ－１分泌促進用組成物

Publications (1)

Publication Number Publication Date
SG11202111833YA true SG11202111833YA (en) 2021-11-29

Family

ID=72942505

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111833YA SG11202111833YA (en) 2019-04-26 2020-04-22 Composition for promoting glp-1 secretion

Country Status (8)

Country Link
US (1) US20220211731A1 (https=)
EP (1) EP3960201A4 (https=)
JP (1) JP7450612B2 (https=)
CN (1) CN113747921A (https=)
AU (1) AU2020263747A1 (https=)
SG (1) SG11202111833YA (https=)
TW (1) TWI790434B (https=)
WO (1) WO2020218379A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202111838SA (en) * 2019-04-26 2021-11-29 Suntory Holdings Ltd Glp-1 secretion-promoting composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139309A (ja) * 1983-01-28 1984-08-10 Nonogawa Shoji:Kk 乳化化粧料
JPH0710338B2 (ja) * 1987-12-28 1995-02-08 有限会社野々川商事 多価アルコール中油型乳化組成物及び水中油型乳化組成物
EP1941899A4 (en) * 2005-09-30 2009-11-11 Morinaga Milk Industry Co Ltd MEANS OF PROMOTING THE SECRETION OF GLUCAGONE-ARTICLE PEPTIDE 1, FOOD OR DRINKING TO PROMOTE THE SECRETION OF GLUCAGONE-ARTICLE PEPTIDE 1, TO REPRESENT THE POSTPRANDIAL INCREASE IN THE BLOOD SUGAR MIRROR AND FOOD OR BEVERAGE FOR THE SUPPRESSION OF THE POSTPRANDIAL RISE IN THE BLOOD SUGAR MIRROR
US8420147B2 (en) * 2009-10-15 2013-04-16 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie cake containing the same
US20120196019A1 (en) * 2011-02-01 2012-08-02 Jingang Shi Stevia sweetener with a surfactant
MX2016009566A (es) * 2014-01-29 2016-12-14 Cargill Inc Suspension estable de un glucósido de esteviol en sirope concentrado.
US10772346B2 (en) * 2014-02-21 2020-09-15 James and Carol May Family, LLLP Compositions and methods for the solubilization of stevia glycosides
US11202461B2 (en) * 2014-09-02 2021-12-21 Purecircle Sdn Bhd Stevia extracts
SG11201800675PA (en) * 2015-07-27 2018-02-27 Suntory Holdings Ltd Composition containing cyclic dipeptide and sweetening agent
WO2017159725A1 (ja) 2016-03-16 2017-09-21 サントリーホールディングス株式会社 Ｇｌｐ－１分泌促進用組成物及びその製造方法
ES2963262T3 (es) * 2017-08-08 2024-03-26 eBIO Nutritional Sciences LLC Composición edulcorante y métodos para elaborarla

Also Published As

Publication number Publication date
JPWO2020218379A1 (https=) 2020-10-29
TWI790434B (zh) 2023-01-21
CN113747921A (zh) 2021-12-03
EP3960201A4 (en) 2023-01-25
JP7450612B2 (ja) 2024-03-15
EP3960201A1 (en) 2022-03-02
TW202106310A (zh) 2021-02-16
AU2020263747A1 (en) 2021-12-09
WO2020218379A1 (ja) 2020-10-29
US20220211731A1 (en) 2022-07-07

Similar Documents

Publication Publication Date Title
JP6208671B2 (ja) 満腹を誘導する方法および組成物
JP5876205B2 (ja) Ｄ−ソルボースからなる甘味料におけるｄ−ソルボースの甘味の不足や、甘味の持続を改良する方法
JP4205870B2 (ja) 生活習慣病予防・改善剤
KR20060119706A (ko) 생활 습관병 예방ㆍ개선용의 유지 가공 조성물
SG11202111833YA (en) Composition for promoting glp-1 secretion
US20220226354A1 (en) Glp-1 secretion-promoting composition
JP2008247858A (ja) ダイエット用の経口摂取用組成物
WO2020218381A1 (ja) Ｇｌｐ－１分泌促進用組成物
JP7090849B2 (ja) 肝機能改善用組成物及び肝機能改善用食品組成物
JP2013150635A (ja) ダイエット用の経口摂取用組成物
CA2578952C (en) Waxy corn starch and use thereof for treating obesity and diabetes
WO2020218383A1 (ja) Ｇｌｐ－１分泌促進剤
US20080113937A1 (en) Agent For Preventing And Ameliorating Obesity
JP7218175B2 (ja) 脂質吸着剤
US10532060B2 (en) Serum cholesterol lowering edible product
JP5943516B2 (ja) Ｄ−ソルボースを有効成分とする生体機能改善用甘味料
TW202106308A (zh) Ｇｌｐ－１分泌促進劑
RU2431471C1 (ru) Биологически активная композиция для контроля и управления аппетитом и регулирования веса
JP2012070653A (ja) 血中トリグリセリド濃度上昇抑制材及び血中トリグリセリド濃度上昇抑制方法